Pharmaceuticals from marine sources: past, present and future An overview of why marine natural products are an attractive prospect for future drug discovery, including history of the field, successes in the clinic and challenges associated with gaining clinical approval.…
Clinical trial recruitment in England fell by almost 10% in 2023/2024 There were 18,140 people recruited to interventional industry clinical trials in 2023/2024, compared with 19,984 people in 2022/2023.…
How AI is transforming drug discovery Pharmaceutical companies and start-ups are harnessing AI to improve speed and reduce costs at every stage of the drug discovery and development process.…
‘Beyond weight loss’: what is the future of semaglutide? As warnings mount around the dangerous accessibility of semaglutide products Wegovy and Ozempic as quick weight loss hacks, researchers are questioning whether the drug has wider implications for other conditions.…
Writing for pleasure or pain? This month’s pick of academic papers from Parastou Donyai, chief pharmacist at the Royal Pharmaceutical Society.…
Pulmonary hypertension: recognition, diagnosis and management An overview of the pathogenesis, recognition, diagnosis and treatment of pulmonary hypertension.…
Principles of diagnostic reasoning This article introduces principles and techniques that help prescribers to systematically structure their approach to differential diagnosis.…
How a pharmacist-led primary care clinic can improve respiratory care Nazir Hussain, a specialist respiratory pharmacist at Dudley Integrated Health and Care NHS Trust, shares how he is improving respiratory care by offering GP-based clinics to help patients manage their COPD and asthma.…
Demystifying medical cannabis: five years on from legalisation Although medical cannabis was legalised in the UK in 2018, a lack of evidence for unlicensed products has meant NHS prescribing is still extremely limited while the private market continues to grow.…
NICE says more evidence needed for newer UTI point-of-care tests Several newer point-of-care tests were not recommended in latest guidance from the National Institute for Health and Care Excellence, in which it concluded that more research needs to be carried out on their accuracy.…